BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Häussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE and FibroScan® in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 2011; 17(41): 4581-4589 [PMID: 22147963 DOI: 10.3748/wjg.v17.i41.4581]
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4581.htm
Number Citing Articles
1
Giada Sebastiani, Konstantinos Gkouvatsos, Kostas Pantopoulos. Chronic hepatitis C and liver fibrosisWorld Journal of Gastroenterology 2014; 20(32): 11033-11053 doi: 10.3748/wjg.v20.i32.11033
2
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino. Elastography of the Liver and Beyond2021; : 119 doi: 10.1007/978-3-030-74132-7_9
3
Thierry Poynard, Jordi Bruix, Eugene R. Schiff, Moises Diago, Thomas Berg, Ricardo Moreno-Otero, Andre C. Lyra, Flair Carrilho, Louis H. Griffel, Navdeep Boparai, Ruiyun Jiang, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht. Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized studyJournal of Hepatology 2013; 58(3): 452 doi: 10.1016/j.jhep.2012.11.001
4
Humberto C. Gonzalez, Andrés Duarte-Rojo. Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient OutcomesCurrent Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0508-y
5
Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung. The NETestEndocrinology and Metabolism Clinics of North America 2018; 47(3): 485 doi: 10.1016/j.ecl.2018.05.002
6
Thierry Poynard, Joseph Moussalli, Mona Munteanu, Dominique Thabut, Pascal Lebray, Marika Rudler, Yen Ngo, Vincent Thibault, Helmi Mkada, Frederic Charlotte, Françoise Imbert Bismut, Olivier Deckmyn, Yves Benhamou, Marc Antoine Valantin, Vlad Ratziu, Christine Katlama. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CJournal of Hepatology 2013; 59(4): 675 doi: 10.1016/j.jhep.2013.05.015
7
Ivan Gentile, Nicola Coppola, Giuseppe Pasquale, Raffaele Liuzzi, Maria D’Armiento, Maria Emma Di Lorenzo, Nicolina Capoluongo, Antonio Riccardo Buonomo, Evangelista Sagnelli, Filomena Morisco, Nicola Caporaso, Guglielmo Borgia. A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis CHepatitis Monthly 2013; 13(5) doi: 10.5812/hepatmon.8352
8
Marianne Pavel, Henning Jann, Vikas Prasad, Ignat Drozdov, Irvin M. Modlin, Mark Kidd. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes ProgressiveNeuroendocrinology 2017; 104(2): 170 doi: 10.1159/000446025
9
K. E. Sherman. Therapeutic Approach to the Treatment-Naive Patient With Hepatitis C Virus Genotype 1 Infection: A Step-by-Step ApproachClinical Infectious Diseases 2012; 55(9): 1236 doi: 10.1093/cid/cis628
10
Sherif El Saadany, Hanan Soliman, Dina H. Ziada, Manal Hamisa, Mohamed Hefeda, Amel Selim, Hussien Goraba. Fibroscan versus liver biopsy in the evaluation of response among the Egyptian HCV infected patients to treatmentThe Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(1): 1 doi: 10.1016/j.ejrnm.2015.12.007
11
Anna Malczewska, Beata Kos-Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Oberg, Irvin M. Modlin. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumorsAdvances in Medical Sciences 2020; 65(1): 18 doi: 10.1016/j.advms.2019.10.002
12
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationHealth Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
13
Antonia Lepida, Massimo Colombo, Inmaculada Fernandez, Djamal Abdurakhmanov, Paulo Abrao Ferreira, Simone I. Strasser, Petr Urbanek, Alessandra Mangia, José L. Calleja, Wafae Iraqi, Ralph DeMasi, Isabelle Lonjon-Domanec, Christophe Moreno, Heiner Wedemeyer, Vincent Wong. Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or CirrhosisPLOS ONE 2015; 10(9): e0138503 doi: 10.1371/journal.pone.0138503
14
Siddharth Singh, Andrew J. Muir, Douglas T. Dieterich, Yngve T. Falck-Ytter. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver DiseasesGastroenterology 2017; 152(6): 1544 doi: 10.1053/j.gastro.2017.03.016
15
Keyur Patel, Giada Sebastiani. Limitations of non-invasive tests for assessment of liver fibrosisJHEP Reports 2020; 2(2): 100067 doi: 10.1016/j.jhepr.2020.100067
16
Delphine Bonnet, Matthieu Guivarch, Emilie Bérard, Jean-Marc Combis, Andre Jean Remy, Andre Glibert, Jean-Louis Payen, Sophie Metivier, Karl Barange, Herve Desmorat, Anaïs Palacin, Florence Nicot, Florence Abravanel, Laurent Alric. Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patientsWorld Journal of Hepatology 2014; 6(9): 660-669 doi: 10.4254/wjh.v6.i9.660